Jefferson Scientists Hopeful That Understanding Tumor-Suppressor Protein Function May Someday Lead To Treatment

Scientists at Jefferson Medical College of Thomas Jefferson University in Philadelphia appear to have an important clue to the workings of a gene that normally protects against cancer. Ultimately, by understanding how both the normal and the damaged gene work, scientists may be able to find ways to interfere with the development of cancer.

Charles Brenner, Ph.D., assistant professor of microbiology and immunology, and a member of Jefferson's Kimmel Cancer Center, and his colleagues at the University of Texas in San Antonio, and at the University of Sheffield in England, have distinguished between potential mechanisms by which the FHIT gene works in preventing cancer development.

A report of the researchers' work appears May 12 in the Proceedings of the National Academy of Sciences.

Dr. Brenner and his colleagues used a combined genetic, biochemical and crystallographic approach to gain information about the function of the tumor-suppressor protein, Fhit, the product of the FHIT gene.

According to Dr. Brenner, Fhit is "encoded in the most fragile site of the human genome. The FHIT gene is frequently inactivated early in the development of cancer, especially in lung cancer."

Dr. Brenner and his co-workers sought to understand how the Fhit protein suppresses tumor formation. "We knew that the Fhit protein is an enzyme that binds and cleaves an unusual class of nucleotides in the cell, called ApppA," he explains. "We wanted to determine if the important function of Fhit was to cleave ApppA or signal the presence of this compound in the cell in order to put the brakes on cell growth." Tumors form when the Fhit protein is absent.

New experiments showed that altered forms of the Fhit protein that bind but don't cleave ApppA are actually still working in tumor suppression. "That excluded the idea that the important thing that Fhit

Contact: Steve Benowitz
Thomas Jefferson University

Page: 1 2

Related biology news :

1. Jefferson Lab detector technology aids development of cystic fibrosis therapy
2. Jefferson scientists find gene expression pattern may predict behavior of leukemia
3. Jefferson researchers develop microchip to track genetic signature of cancer and normal tissue
4. Jefferson scientists use gene therapy to restore function of damaged heart cells in lab
5. Jefferson researchers uncover biochemical clues to how cells migrate in embryos
6. Jefferson and Brigham and Womens researchers find blue light important for setting biological clock
7. Jefferson Lab experiment generates THz radiation 20,000 times brighter than anyone else
8. Jefferson scientists show neural stem cells can become dopamine-making brain cells in laboratory
9. Jefferson scientists show how collagen gene mutation leads to osteoarthritis
10. Jefferson scientists use gene repair technique to change albino mice hairs to black
11. Jefferson scientists show drug is effective against a Hepatitis C Virus model in the laboratory

Post Your Comments:

(Date:4/16/2019)... ... April 16, 2019 , ... ... speakers for two signature events: The 2019 ISPE Biopharmaceutical Manufacturing Conference , ... 20–21 June. Taking place in one of the most influential bio hubs, Boston, ...
(Date:4/9/2019)... ... ... The McLeod Center for Cancer Treatment and Research has been ... conducted by an independent, third-party panel of experts in radiation oncology, patient safety and ... McLeod is the only such cancer center in South Carolina. The hospital also represents ...
(Date:4/4/2019)... ALISO VIEJO, Calif. (PRWEB) , ... April 02, ... ... a leading clinical genetics testing company, will present results demonstrating that RNA genetic ... hereditary cancer genetic testing. This study, awarded as a Top Rated poster, is ...
Breaking Biology News(10 mins):
(Date:3/15/2019)... and ATLANTA (PRWEB) , ... ... ... the acquisition of 100% equity in American Process Inc. and affiliate companies ... the Alpena Biorefinery in Alpena Michigan, the Thomaston Biorefinery and R&D center ...
(Date:3/14/2019)... ... ... The growth in the number and complexity of regulations as well as ... intelligence (RI) systems are not keeping with ... and cheaper. With a diversity of information sources, identifying and analyzing context based intelligence ...
(Date:3/14/2019)... , ... March 14, 2019 , ... ... release announcing that its Canadian partner, the Eye Machine Canada Inc., had been ... Oculus’s pioneering technology for treating Age-Related Macular Degeneration (AMD). , The previous month, ...
(Date:3/14/2019)... (PRWEB) , ... March 13, 2019 , ... ... its 2019 ISPE Europe Biotechnology Conference , taking place in Brussels, Belgium ... biotechnology best practices, technical and operational solutions, and innovative approaches. , “Biopharmaceuticals ...
Breaking Biology Technology:
Cached News: